The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Koya Keizo since year 2005.
The trader's CIK number is 1325718.
At the time of this reporting, Koya Keizo is the Sr. VP, Drug Develop of Synta Pharmaceuticals Corp .
(stock ticker symbol SNTA).
See this page for all insider trading activities at Synta Pharmaceuticals Corp .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2012-03-01||SNTA||Synta Pharmaceuticals Corp||Sale||6,844||4.70||32,187|
|2011-04-20||SNTA||Synta Pharmaceuticals Corp||Sale||10,000||5.60||56,000|
|2011-04-25||SNTA||Synta Pharmaceuticals Corp||Sale||10,000||6.00||60,000|
|2011-03-01||SNTA||Synta Pharmaceuticals Corp||Sale||18,270||5.23||95,552|
|2009-08-24||SNTA||Synta Pharmaceuticals Corp||Buy||10,000||2.84||28,430|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Koya Keizo (Sr. VP, Drug Develop of Synta Pharmaceuticals Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.